Related Experiment Videos
Resection for bronchogenic carcinoma in the elderly.
1Thoracic Surgery Department, University of Turin, Italy.
The Journal of Cardiovascular Surgery
|December 22, 1999
Summary
Surgery for non-small cell lung cancer in patients over 70 is worthwhile, showing acceptable long-term survival and low mortality. Careful patient selection significantly impacts survival outcomes, similar to cancer stage.
Area of Science:
- Thoracic Surgery
- Surgical Oncology
- Geriatric Medicine
Background:
- Assessing surgical outcomes for elderly patients (≥70 years) with non-small cell lung cancer (NSCLC).
- Evaluating postoperative complications, mortality, and long-term survival after NSCLC surgery.
- Analyzing prognostic factors influencing surgical results in geriatric lung cancer patients.
Purpose of the Study:
- To evaluate the safety and efficacy of surgical treatment for NSCLC in elderly patients.
- To identify predictors of mortality, morbidity, and survival in this demographic.
- To determine the impact of patient selection criteria on long-term outcomes.
Main Methods:
- Retrospective review of 258 patients aged 70+ undergoing lung cancer surgery (1980-1997).
- Comparison of outcomes between a highly selected group (first 11 years) and a less restricted group (post-1990).
- Multivariate analysis to identify significant prognostic factors for survival.
Main Results:
- Overall postoperative mortality was 3.1%; morbidity was 39.1%.
- Pneumonectomy was associated with higher mortality (9.1%, p=0.03).
- Stage and selection criteria significantly impacted 5-year survival (Stage I: 73.6%, Stage IIIa: 8.9%; highly selected: 57%, others: 40%).
Conclusions:
- Patient selection criteria have a significant impact on survival, comparable to cancer stage.
- Surgery is a viable option for elderly patients with NSCLC, offering acceptable long-term survival and low mortality.
- Long-term studies should carefully consider the influence of selection criteria in geriatric surgical oncology.